Welcome to IntegraGen's News and Events page. Here you will find current and archived press releases, listings of upcoming events, and news coverage about the company and some of its projects and initiatives.
Contact us if you would like more information about IntegraGen and our efforts.
14 February 2018
IntegraGen announces a global distribution agreement with Twist Bioscience for IntegraGen’s portfolio of genomic data analysis tools. The agreement includes distribution rights for SIRIUS™, an online Big Data solution that assists researchers to quickly and intuitively analyze exome data for Mendelian and oncology applications, and MERCURY™, an online (…) »
25 January 2018
IntegraGen today announced the addition of Twist Bioscience Corporation’s Human Core Exome Complete Kit, a streamlined library prep and exome enrichment solution, to its next-generation targeted sequencing product offerings. Under the terms of the agreement Twist Bioscience will provide IntegraGen its Human Core Exome Complete Kit for all target (…) »
18 January 2018
IntegraGen today announced the launch of SIRIUS™ and MERCURY™, two separate Big Data SaaS tools which enable the extensive exploration of large scale genomic data to assist in the diagnosis and management of patients.
Click here to view press release.
09 January 2018
09 January 2018
IntegraGen and GoPath Laboratories announced today the signing of a non-exclusive licensing agreement allowing GoPath to develop and provide a test based on IntegraGen’s proprietary miR-31-3p biomarker to physicians in the United States and Canada. The test will complement GoPath’s specialized molecular diagnostic testing portfolio for cancer and enable clinicians to (…) »
06 January 2018
IntegraGen will be in attendance at 36th Annual JP Morgan Healthcare Conference being held in San Francisco on January 8 – 11, 2018. The J.P. Morgan Healthcare Conference is the largest and most informative healthcare investment symposium in the industry which brings together global industry leaders, emerging fast-growth (…) »
21 November 2017
IntegraGen’s CEO, Bernard Courtieu has been invited to speak at the University of Montreal Hospital Research Centre (CRCHUM) on November 27, 2017 as a part of their CRCHUM Conference series. Dr. Courtieu will be speaking on the topic “From research to routine clinical practice: bioinformatic tools are permitting (…) »
11 November 2017
IntegraGen will participate in The Jefferies 2017 London Healthcare Conference taking place 15 and 16 November 2017 in London, UK.
The Jefferies Conference is the largest healthcare-dedicated conference in Europe with over 350 participating companies, 1,400 attendees and 3,400 business-to-business and investor meetings. The event will feature (…) »
30 October 2017
IntegraGen today announced that it received the 2017 Galien MedStartUp award for “Best Collaboration for a Breakthrough Therapy or Diagnosis” during the recent MedStartUp Days conference held in New York City. IntegraGen was presented the award based on its collaboration with The Solution Lab, a non-profit organization which (…) »
23 October 2017
IntegraGen has been nominated for a 2017 MedStartup award, an initiative between The Galien Foundation and Business France to encourage and reward international partnerships between French and North American innovators in the Life Sciences Industry. IntegraGen was selected as a nominee by an (…) »